ncponc_2005_169.indd
brb.nci.nih.gov · 1,558 words · saved by 1 readers
N/A
VIEWPOINT www.nature.com/clinicalpractice/onc The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens Richard Simon* and Larry Norton R Simon is Chief Successful treatment of bacterial infections integrated drug effect, the chance of eradi- of the Biometric is largely a result of our ability to exploit the cating the tumor is maximized by delivering Research Branch…
saved by
related reading
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Cancersytse.com
- The Minimum Effective Dose: Why Less is Morefs.blog
- Systemic Bottlenecks & Misalignmentscurecancer.ai
- Clinic-in-the-Loopasimov.press
- Eroom's law - Wikipediaen.wikipedia.org
- Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancerncbi.nlm.nih.gov
- A primer on why computational predictive toxicology is hardowlposting.com
- Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variablespmc.ncbi.nlm.nih.gov
- Summing up cancer stem cellsnature.com
- OCTO - Noetiknoetik.ai
- Current and Emerging Approaches for Spine Tumor Treatmentpmc.ncbi.nlm.nih.gov